SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-14-026295
Filing Date
2014-04-08
Accepted
2014-04-08 09:16:28
Documents
2
Period of Report
2014-04-07
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a14-10147_18k.htm 8-K 22927
2 EX-3.1 a14-10147_1ex3d1.htm EX-3.1 79911
  Complete submission text file 0001104659-14-026295.txt   104193
Mailing Address 119 FOURTH AVE NEEDHAM MA 02494-2725
Business Address 119 FOURTH AVE NEEDHAM MA 02494 7814330771
Celldex Therapeutics, Inc. (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-15006 | Film No.: 14750054
SIC: 2835 In Vitro & In Vivo Diagnostic Substances